Rare disease pharmaceutical service market to reach $245.14 billion by 2030 at 12.9% CAGR, driven by rise of personalized medicine.
Read More
Rare disease genome editing market to reach $2.88 billion by 2030 at 17.5% CAGR, driven by increasing focus on precision medicine.
Read More
The global ranibizumab market to reach $3.31 billion by 2030 at 3.6% CAGR, driven by increasing prevalence of eye diseases.
Read More
The global radioligand therapy market to reach $10.72 billion by 2030 at 10.0% CAGR, driven by increasing cancer incidence.
Read More
The global racecadotril market to reach $4.9 billion by 2030 at 7.3% CAGR, driven by rising incidence of diarrhea.
Read More
Quit smoking drugs market to reach $90.73 billion by 2030 at 15.5% CAGR, driven by growing prevalence of smoking addiction.
Read More
Quinolones market to reach $66.44 billion by 2030 at 5.1% CAGR, driven by increasing danger of antimicrobial resistance.
Read More
The global quinine sulfate market to reach $3.81 billion by 2030 at 8.0% CAGR, driven by growing malaria incidence.
Read More
The global quinine market to reach $3.76 billion by 2030 at 8.8% CAGR, driven by rising prevalence of malaria.
Read More
Quadrivalent market to reach $15.37 billion by 2030 at 10.1% CAGR, driven by rising immunization coverage across the world.
Read More